2BGXS-G2Contactless nocturnal monitor

FINAL DRAFT Albus Home G2 User Manual v1.0EN FINAL DRAFT ALB-OF-102 ©2024 BreatheOx Ltd 1 ENGLISH Albus Home G2 User Manual Introduction and Intended Use Albus Home (Research Device) is a home monitoring device for the recording of night-time symptoms and signs, being provided to you as part of your participation in a research study. Please note that this device is only intended for use in research and is not intended for medical or clinical care or practice for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. Please read this user manual thoroughly before using Albus Home. Please keep this manual for future reference. Safety Information Safety Cautions Caution: Indicates a potentially hazardous situation which, if not avoided, may result in minor or moderate impact to the health of patients. • Only the certified power adaptor provided should be used. The condition of the power adaptor should be periodically checked. Do not use if the power adaptor is damaged or the cables are frayed. • Keep out of reach of young children. Please ensure the power cable does not pose a tripping or strangling risk. • Avoid contact with liquid or with corrosive materials. • If the device gets wet or starts overheating stop using immediately and disconnect the power supply from mains power. FINAL DRAFT Albus Home G2 User Manual v1.0EN FINAL DRAFT ALB-OF-102 ©2024 BreatheOx Ltd 2 ENGLISH • To avoid risk of fire, do not use in the presence of flammable gasses or vapors. Do not cover the device. • Do not open the device, remove any parts from the device, or attempt to perform any repairs. Do not insert anything into the device, and do not use if this occurs. • Minimum distance between front of device and user (during monitoring): 20cm (8”). • Operating temperature range: 0-40°C (32-104°F) • Do not use outside the specified operating conditions. General Precautions • The Mains power adaptor should not be used for any other device. • To avoid mechanical or electrical damage, please take care not to drop the unit. If accidentally dropped, please contact the study team who can check it is still functioning properly. • Placing objects between the device and the user may impair its performance. • In the event of a power failure the device will not operate, but it will reboot automatically when power returns. Installation and Positioning If needed, a member of the study team may request additional information about how you have installed it, to ensure it is correct. BACK FRONT FINAL DRAFT Albus Home G2 User Manual v1.0EN FINAL DRAFT ALB-OF-102 ©2024 BreatheOx Ltd 3 ENGLISH Before placement, please plug the device into the mains socket (using the supplied mains power adaptor). While the device is booting up, the light will turn red then white. After 2-3 minutes, the light should turn Blue (standby) or Green (monitoring). If the light does not come on at all, or keeps blinking, or stays red or white after 5 minutes, please inform the study team. The device is designed to be placed on your bedside table/nightstand or other flat-top furniture as shown in the image. Please keep the following in mind: • Place on the table corner closer to you and the wall, such that the corners of the device align with the corners of the table. The front of the device should naturally face you. • If the bed is shared with others, place the device on the side nearer to you. • The device should not be lower than your mattress. • The device should be at least 20cm (8”) from you during monitoring. • Ensure no objects are placed in front of the device, so that it can work properly. • If the position of the device has accidentally moved during use, please simply move it back to a similar position as before. • Please do not place vibrating objects directly in front of or in contact with the device or the table/nightstand on which the device is placed. Most typical bedroom devices (e.g. TVs, radios, fans) are ok to continue using together with the Albus Home, sometimes with small adjustments. If you use any night-time device or equipment, please let the study team know, who will be happy to advise you. Positioning Support and Accessories FINAL DRAFT Albus Home G2 User Manual v1.0EN FINAL DRAFT ALB-OF-102 ©2024 BreatheOx Ltd 4 ENGLISH If you are unsure about any aspects of positioning the device, please get in touch with the study team. If you do not have a bedside table/nightstand, or if it is lower than your mattress, please speak to your study team who can provide accessories to support the installation of the device. Ongoing use Albus Home should be kept continuously plugged in to the mains power (using the supplied adaptor). The device uses minimal electricity, consuming less than 0.2kWh per day, similar to a tablet such as an iPad. During use, the device might sometimes feel a little warm, but this is normal. Albus Home has been designed and tested to be safely kept plugged in long-term. The device is programmed to monitor the night-time symptoms and signs automatically for maximum convenience – there is nothing that you need to do. You can sleep in your usual sleeping positions, with or without co-sleepers and using your usual clothing and blankets. To ensure privacy, any speech detected will be automatically deleted and will not be stored or transferred. The device automatically starts and stops according to hours the study team will pre-set with you. You can record those here: Start time: _______________________ End time: _______________________ Adjusting light and screen brightness You can press the + and – buttons at the back of the device to increase or reduce the brightness of the screen and light to your preferences. The following are the states of the device during ongoing use: Higher Lower FINAL DRAFT Albus Home G2 User Manual v1.0EN FINAL DRAFT ALB-OF-102 ©2024 BreatheOx Ltd 5 ENGLISH Standby When outside of pre-set start and end times, the device remains in Standby mode and no monitoring or data collecti…

Text truncated - open the document above for the full version.

BreatheOx Ltd (t/a Albus Health), Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP +44(0)1865 989513 www.albushealth.com v2.0/0824 Date: 16 th August 2024 To: Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia, MD 21046 USA Ref: Attestation Statements Part 2.911(d)(5)(i) and Part 2.911(d)(5)(ii) Filing Re. KDB 986446 D01 FCC ID: 2BGXS-G2 Dear Sir or Madam, BreatheOx Limited (“the applicant”) certifies that the equipment for which authorization is sought is not “covered” equipment prohibited from receiving an equipment authorization pursuant to section 2.903 of the FCC rules. We also certify that, as of the date of the filing of the application, the applicant is not identified on the Covered List as an entity producing “covered” equipment. If you have any questions, please contact us. Sincerely, Dr Dan Green, Chief Operating Officer E: [email protected] T: +44 7967 611234

BreatheOx Ltd (t/a Albus Health), Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP +44(0)1865 989513 www.albushealth.com V02072023 Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia, MD 21046 USA Date: 12 August 2024 Ref: Attestation Statement Part 2.911(d)(7) Filing FCC ID:28GXS-G2 BreatheOx Limited (dba Albus Health) certifies that, as of the dates of this application, Americas Compliance Consulting LLC dba iCertifi “iCertifi” is our designated U.S. agent for service of process for the above referenced FCC ID. BreatheOx Ltd accepts to maintain an agent for no less than one year after the grantee has terminated all marketing and importation or the conclusion of any commission-related proceeding involving the equipment. iCertifi accepts, as of the date of the filing of the application, the obligation of the designated U.S. agent for service process for the above referenced FCC ID. Designated U.S. Agent Information: Name: Americas Compliance consulting, LLC dba iCertifi FCC FRN: 0033399411 Address: 2445 NE Division Street, Suite 202 Bend, OR 97703 United States Contact Person: Paul Preston Tel: 866-885-4575 Email: [email protected] Sincerely, BreatheOx Ltd dba Albus Health 0035548197 Americas Compliance Consulting LLC dba iCertifi Dan Green, COO Paul Preston

BreatheOx Ltd (t/a Albus Health), Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP +44(0)1865 989513 www.albushealth.com v2.0/0824 Date: 16 th August 2024 To: Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia, MD 21046 USA Ref: Grantee Name: BreatheOx Limited Grantee Code: 2BGXS Dear Sir or Madam, For the avoidance of doubt, I write to confirm that our company BreatheOx Limited uses a trading name of ‘Albus Health’. References to Albus Health, including those in our official letterhead, shall be construed as references to BreatheOx Limited, the incorporated legal entity and FCC Grantee. If you have any questions, please contact me. Sincerely, Dr Dan Green, Chief Operating Officer E: [email protected] T: +44 7967 611234

BreatheOx Ltd (t/a Albus Health), Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP +44(0)1865 989513 www.albushealth.com v2.0/0824 Date 16 th August 2024 TUV SUD BABT UNLIMITED (TCB) Octagon House, Concorde Way Segensworth North, Fareham, Hampshire, PO15 5RL Confidentiality Request FCC ID: 2BGXS-G2 Pursuant to FCC 47 CFR 0.457(d)(1)(ii) and FCC 47 CFR 0.459 of the Commission’s Rules, BreatheOx Limited hereby requests permanent confidential treatment of information accompanying this application as outlined below: • Schematics • Bill of Materials • Block Diagrams • Operational Description The above materials contain trade secrets and proprietary information not customarily released to the public. The public disclosure of these matters might be harmful to the Applicant and provide unjustified benefits to its competitors. Yours sincerely, Dr Dan Green, Chief Operating Officer E: [email protected] T: +44 7967 611234

Albus Home G2 – External photos Front of device: Back of device: Bottom of device: Side of device: 45 degree view from top of device:

Albus Home G2 – ID Labels, Form and Positioning ID label a(ixed to bottom surface of device: Photograph showing placement of ID label: Device packaging – rear of box: Device packaging – 3D view of packaging:

Albus Home G2 – Internal & Circuit Board photos Back of device with cover removed (view 1 – WiFi antenna): WiFi Antenna Back of device with cover removed (view 2 – Cellular antenna): Cellular Antenna Bottom of device with cover removed: Internal board- Main Board (top – with compute module): Internal board- Main Board (bottom – with compute module): Internal board- Main Board (top – without compute module): Internal board- Main Board (bottom – without compute module): Internal board- Power Board (top): Internal board- Power Board (bottom): Internal board- Radar Board (top – antenna is on-package): Radar chip (antenna on package) Internal board- Radar Board (bottom):

FCC MPE calculation Albus Home G2 The Albus Home G2 contains three radio transmitters: • Quectel EG25 Cellular Modem. FCC ID: XMR201903EG25G and IC: 10224A-201903EG25G with Molex- 209142-0180 antenna which has gains of: o 1.2 dBi maximum between 698 and 960 MHz o 5.2 dBi maximum between 1710 and 2690 MHz • Laird LWB5+ WiFi Modem, FCC ID:SQG-LWB5PLUS and IC ID:3147A-LWB5PLUS with Ezurio (formerly Laird)- EMF2449A1-10MH4L antenna which has gains of: o 2.8 dBi maximum between 2400 - 2500 MHz o 3.4 dBi maximum between 4900 – 5875 MHz • FMCW transmitter with integral antenna RF Exposure – USA evaluation of mobile device to 2.1091 The Albus Home G2 is powered by an external mains-DC power supply and is designed to be placed on a bedside table or similar location at a distance of 50 – 150 cm from the body being measured by the 60 GHz radar. For Mobile use, the safe distance from the antenna is the greater of: 20cm Or r cm, where r = √ (PG/4πS) 1 P: power input to antenna(s) in mW G: numeric gain of antenna relative to isotropic radiator S: power density in mW/cm 2 The maximum permitted values of S for general population / uncontrolled exposure are: • F/1500 mW/cm 2 for frequencies 300 – 1500 MHz • 1.0 mW/cm 2 for frequencies above 1500 MHz For the purposes of this calculation of minimum distance “r” is calculated assuming all three radios are transmitting simultaneously and is made by summing the EIRP of the three radios, so the WiFi transmit power and 60 GHz transmit power are added to the cellular power and compared to the limit for the cellular band in question. The table of calculations is on the page below, but all values of r are ≤ 16.04 cm so the safe distance is 20 cm. The limit for S is given in 47CFR1.1310(e)(1) table 1: 1 This is derived from the formula S = 푃퐺 4휋푟 2 in OET Bulletin 65 FCC MPE calculation Albus Home G2 Frequency Band Lowest Freq. (MHz) Cellular modem WiFi radio EIRP (mW) 2 FMCW EIRP (mW) 3 Limit for S (mW/cm 2 ) Minimum r (cm) for S < limit S (mW/cm 2 ) at 20 cm distance Transmit power (W) 4 Antenna gain (dBi) EIRP (mW) LTE band 2 1850 0.4198 2.7 781.7 556.4 0.153 1.00 10.32 0.27 LTE band 4 1710 0.4887 2.7 910.0 556.4 0.153 1.00 10.80 0.29 LTE band 5 824 0.2582 1.2 340.4 556.4 0.153 0.55 11.40 0.18 LTE band 7 2500 0.4864 2.7 905.7 556.4 0.153 1.00 10.79 0.29 LTE band 12 698 0.3475 1.2 458.1 556.4 0.153 0.47 13.17 0.20 LTE band 13 777 0.4395 1.2 579.4 556.4 0.153 0.52 13.21 0.23 LTE band 25 1850 0.4111 2.7 765.5 556.4 0.153 1.00 10.26 0.26 LTE band 26 (pt90) 814 0.2455 1.2 323.6 556.4 0.153 0.54 11.36 0.18 LTE band 26 (pt22) 824 0.2582 1.2 340.4 556.4 0.153 0.55 11.40 0.18 LTE band 38 2570 0.3926 2.7 731.1 556.4 0.153 1.00 10.12 0.26 LTE band 41 2496 0.4853 2.7 903.7 556.4 0.153 1.00 10.78 0.29 GSM 850 824 1.8493 1.2 1218.9 5 556.4 0.153 0.55 16.04 0.35 GSM 1900 1850 1.3335 2.7 1241.5 3 556.4 0.153 1.00 11.96 0.36 UMTS band 2 1850 0.3524 2.7 656.2 556.4 0.153 1.00 9.82 0.24 UMTS band 4 1710 0.3819 2.7 711.1 556.4 0.153 1.00 10.04 0.25 UMTS band 5 824 0.2512 1.2 331.1 556.4 0.153 0.55 11.34 0.18 2 From FCC Grant for FCC ID: which confirms that highest transmit power in 2.4 GHz band is 0.292 W and 0.101 W in the 5 GHz band, so 2.4 GHz band with 2.8 dBi antenna is worst case transmit power. 3 TUV report 75961718-02 gives radiated power as 13.65 dBm with a duty cycle of 0.66%. 4 From FCC Grant for FCC ID: XMR201903EG25G 5 Power reduced by 50% as maximum of 4 time slots are supported by GPRS

TÜV SÜD is a trading name of TUV SUD Ltd Registered in Scotland at East Kilbride, Glasgow G75 0QF, United Kingdom Registered number: SC215164 TUV SUD Ltd is a TÜV SÜD Group Company Phone: +44 (0) 1489 558100 Fax: +44 (0) 1489 558101 www.tuvsud.com/en TÜV SÜD Octagon House Concorde Way Fareham Hampshire PO15 5RL United Kingdom TÜV SÜD SIGNATURE NAME JOB TITLE RESPONSIBLE FOR ISSUE DATE Steve Marshall Senior Engineer Authorised Signatory 16 August 2024 Signatures in this approval box have checked this document in line with the requirements of TÜV SÜD document control rules. ENGINEERING STATEMENT The measurements shown in this report were made in accordance with the procedures described on test pages. All reported testing was carried out on a sample equipment to demonstrate limited compliance with FCC 47 CFR Part 15C and ISED RSS-210 and ISED RSS-GEN. The sample tested was found to comply with the requirements defined in the applied rules. RESPONSIBLE FOR NAME DATE SIGNATURE Testing Matthew Dawkins 16 August 2024 Testing Matthew Russell 16 August 2024 FCC Accreditation 492497/UK2010 Octagon House, Fareham Test Laboratory ISED Accreditation 12669A/UK0003 Octagon House, Fareham Test Laboratory EXECUTIVE SUMMARY A sample of this product was tested and found to be compliant with FCC 47 CFR Part 15C: 2023, ISED RSS-210: Issue 10 (12- 2019) + A1 (2020-04) and ISED RSS-GEN:Issue 05 (2018-04) + A2 (2021-02) for the tests detailed in section 1.3. FCC and ISED Test Report BreatheOx Limited T/A Albus Health Albus Home, Model: G2 In accordance with FCC 47 CFR Part 15C and ISED RSS-210 and ISED RSS-GEN (60 GHz Radio) Prepared for: BreatheOx Limited T/A Albus Health 9400 Garsington Road, Oxford Business Park, Oxford, Oxfordshire, OX4 2HN UNITED KINGDOM FCC ID: 2BGXS-G2 IC: 32679-G2 COMMERCIAL-IN-CONFIDENCE Document 75961718-02 Issue 02 DISCLAIMER AND COPYRIGHT This non-binding report has been prepared by TÜV SÜD with all reasonable skill and care. The document is confidential to the potential Client and TÜV SÜD. No part of this document may be reproduced without the prior written approval of TÜV SÜD. © 2024 TÜV SÜD. This report relates only to the actual item/items tested. ACCREDITATION Our UKAS Accreditation does not cover opinions and interpretations and any expressed are outside the scope of our UKAS Accreditation. Results of tests not covered by our UKAS Accreditation Schedule are marked NUA (Not UKAS Accredited). Results of tests covered by our Flexible UKAS Accreditation Schedule are marked FS (Flexible Scope). Document 75961718-02 Issue 02 COMMERCIAL-IN-CONFIDENCE COMMERCIAL-IN-CONFIDENCE Page 1 of 38 Contents 1 Report Summary .........................................................................................................................2 1.1 Report Modification Record ...........................................................................................................2 1.2 Introduction ....................................................................................................................................2 1.3 Brief Summary of Results .............................................................................................................3 1.4 Application Form ...........................................................................................................................4 1.5 Product Information .......................................................................................................................8 1.6 Deviations from the Standard ........................................................................................................8 1.7 EUT Modification Record ..............................................................................................................8 1.8 Test Location .................................................................................................................................9 2 Test Details ............................................................................................................................... 10 2.1 AC Power Line Conducted Emissions ....................................................................................... 10 2.2 Equivalent Isotropically Radiated Power .................................................................................... 14 2.3 Spurious Radiated Emissions .................................................................................................... 18 2.4 Frequency Stability and Emission Bandwidth ............................................................................ 32 3 Photographs ............................................................................................................................. 35 3.1 Test Setup Photographs ............................................................................................................ 35 4 Measurement Uncertainty ....................................................................................................... 38 Document 75961718-02 Issue 02 COMMERCIAL-IN-CONFIDENCE COMMERCIAL-IN-CONFIDENCE Page 2 of 38 1 Report Summary 1.1 Report Modification Record Alterations and additions to this report will be issued to the holders of each copy in the form of a complete document. Issue Description of Change Date of Issue 1 First Issue 30-July-2024 2 Second Issue – UKAS accreditation status 16-August-2024 Table 1 1.2 Introduction Applicant BreatheOx Limited T/A Albus Health Manufacturer BreatheOx Limited T/A Albus Health Model Number(s) G2 Serial Number(s) 28330003 and 28330004 Hardware Version(s) v2 Software Version(s) V21.00.00 Number of Samples Tested 2 Test Specification/Issue/DateR FCC 47 CFR Part 15C: 2023 ISED RSS-210: Issue 10 (12-2019) + A1 (2020-04) ISED RSS-GEN: Issue 05 (2018-04) + A2 (2021-02) Order Number Date PO-0001 10-June-2024 Date of Receipt of EUT 14-June-2024 Start of Test 29-June-2024 Finish of Test 19-July-2024 Name of Engineer(s) Matthew Dawkins and Matthew Ru…

Text truncated - open the document above for the full version.

TÜV SÜD is a trading name of TUV SUD Ltd Registered in Scotland at East Kilbride, Glasgow G75 0QF, United Kingdom Registered number: SC215164 TUV SUD Ltd is a TÜV SÜD Group Company Phone: +44 (0) 1489 558100 Fax: +44 (0) 1489 558101 www.tuvsud.com/en TÜV SÜD Octagon House Concorde Way Fareham Hampshire PO15 5RL United Kingdom TÜV SÜD SIGNATURE NAME JOB TITLE RESPONSIBLE FOR ISSUE DATE Steve Marshall Senior Engineer Authorised Signatory 30 July 2024 Signatures in this approval box have checked this document in line with the requirements of TÜV SÜD document control rules. ENGINEERING STATEMENT The measurements shown in this report were made in accordance with the procedures described on test pages. All reported testing was carried out on a sample equipment to demonstrate limited compliance with FCC 47 CFR Part 2, FCC 47 CFR Part 15, FCC 47 CFR Part 24, FCC 47 CFR Part 27, ISED RSS-130, ISED RSS-133, ISED RSS-210 & ISED RSS-GEN. The sample tested was found to comply with the requirements defined in the applied rules. RESPONSIBLE FOR NAME DATE SIGNATURE Testing Aakash Rawal 30 July 2024 FCC Accreditation 492497/UK2010 Octagon House, Fareham Test Laboratory ISED Accreditation 12669A/UK0003 Octagon House, Fareham Test Laboratory EXECUTIVE SUMMARY A sample of this product was tested and found to be compliant with FCC 47 CFR Part 2: 2022, FCC 47 CFR Part 15: 2022, FCC 47 CFR Part 24: 2022, FCC 47 CFR Part 27: 2022, ISED RSS-130: Issue 2 (02-2019), ISED RSS-133: Issue 6 (01-2018), ISED RSS- 210: Issue 10 (12-2019) + A1 (04-2020) & ISED RSS-GEN: Issue 5 (04-2018) + A2 (02-2021) for the tests detailed in section 1.3. FCC and ISED Test Report BreatheOx Limited T/A Albus Health Albus Home, Model: G2 In accordance with FCC 47 CFR Part 2, FCC 47 CFR Part 15, FCC 47 CFR Part 24, FCC 47 CFR Part 27, ISED RSS-130, ISED RSS-133, ISED RSS-210 & ISED RSS- GEN (4G & 60 GHz Radio) Prepared for: BreatheOx Limited T/A Albus Health 9400 Garsington Road, Oxford Business Park, Oxford, Oxfordshire OX4 2HN UNITED KINGDOM FCC ID: 2BGXS-G2 IC: 32679-G2 COMMERCIAL-IN-CONFIDENCE Document 75961718-03 Issue 01 DISCLAIMER AND COPYRIGHT This non-binding report has been prepared by TÜV SÜD with all reasonable skill and care. The document is confidential to the potential Client and TÜV SÜD. No part of this document may be reproduced without the prior written approval of TÜV SÜD. © 2024 TÜV SÜD. This report relates only to the actual item/items tested. ACCREDITATION Our UKAS Accreditation does not cover opinions and interpretations and any expressed are outside the scope of our UKAS Accreditation. Results of tests not covered by our UKAS Accreditation Schedule are marked NUA (Not UKAS Accredited). Results of tests covered by our Flexible UKAS Accreditation Schedule are marked FS (Flexible Scope). Document 75961718-03 Issue 01 COMMERCIAL-IN-CONFIDENCE COMMERCIAL-IN-CONFIDENCE Page 1 of 21 Contents 1 Report Summary .........................................................................................................................2 1.1 Report Modification Record ...........................................................................................................2 1.2 Introduction ....................................................................................................................................2 1.3 Brief Summary of Results .............................................................................................................3 1.4 Application Form ...........................................................................................................................4 1.5 Product Information .......................................................................................................................8 1.6 Deviations from the Standard ........................................................................................................8 1.7 EUT Modification Record ..............................................................................................................8 1.8 Test Location .................................................................................................................................8 2 Test Details ..................................................................................................................................9 2.1 Radiated Spurious Emissions (Simultaneous Transmission) .......................................................9 3 Photographs ............................................................................................................................. 19 3.1 Test Setup Photographs ............................................................................................................ 19 4 Measurement Uncertainty ....................................................................................................... 21 Document 75961718-03 Issue 01 COMMERCIAL-IN-CONFIDENCE COMMERCIAL-IN-CONFIDENCE Page 2 of 21 1 Report Summary 1.1 Report Modification Record Alterations and additions to this report will be issued to the holders of each copy in the form of a complete document. Issue Description of Change Date of Issue 1 First Issue 30-July-2024 Table 1 1.2 Introduction Applicant BreatheOx Limited T/A Albus Health Manufacturer BreatheOx Limited T/A Albus Health Model Number(s) G2 Serial Number(s) 28330004 Hardware Version(s) v2 Software Version(s) V21.00.00 Number of Samples Tested 1 Test Specification/Issue/Date FCC 47 CFR Part 2: 2022 FCC 47 CFR Part 15: 2022 FCC 47 CFR Part 24: 2022 FCC 47 CFR Part 27: 2022 ISED RSS-130: Issue 2 (02-2019) ISED RSS-133: Issue 6 (01-2018) ISED RSS-210: Issue 10 (12-2019) + A1 (04-2020) ISED RSS-GEN: Issue 5 (04-2018) + A2 (02-2021) Order Number Date PO-0001 10-June-2024 Date of Receipt of EUT 14-June-2024 Start of Test 25-June-2024 Finish of Test 26-June-2024 Name of Engineer(s) Aakash Rawal Related Document(s) ANSI C63.26 (2015) ANSI C63.10 (2020) ANSI C63.4 (2014) KDB 996369 D04 Module …

Text truncated - open the document above for the full version.

Document 75961718-02 Issue 01 COMMERCIAL-IN-CONFIDENCE COMMERCIAL-IN-CONFIDENCEPage 35 of 38 3Photographs 3.1 Test Setup Photographs Figure 20-30 MHz to 1 GHz Figure 21-1GHz to 18 GHz Document 75961718-02 Issue 01 COMMERCIAL-IN-CONFIDENCE COMMERCIAL-IN-CONFIDENCEPage 36 of 38 Figure 22-18 GHz to 40 GHz Figure 23-40 GHz to 90 GHz Document 75961718-02 Issue 01 COMMERCIAL-IN-CONFIDENCE COMMERCIAL-IN-CONFIDENCEPage 37 of 38 Figure 24-90 GHz to 200 GHz